Korea has strong R&D powerhouse, Pfizer management says

Published: 2006-09-13 06:59:00

Updated: 2006-09-13 06:59:00

"I am really surprised at Korean researchers and facilities for their top-notch expertise in basic and clinical testing," said Declan Doogan, vice president of Pfzier Inc. prior to his departure immediately after his 20 delegates attended BIO KOREA 20006.

In meeting with Pfizer Korea officials, Doogan said that he was deeply impressed with Korean's "aspiration" for the future and that this m...

Fees

- Email service daily and homepage access.

$300 per month.
5 Email holders per each company.
Anual contract base.